Fewer studies with small sample sizes have demonstrated that patients with FTD have thinner outer retinal thickness compared to controls (Kim et al., 2017; Kim et al., 2019) and that outer nuclear layer (ONL) thickness may be helpful in distinguishing FTLD-Tau from AD neuropathologic changes (Kim et al., 2023). Here, MAPT is linked to Alzheimer disease.